Lamotrigine Tablet
Product Images NDC 67877-165

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 67877-165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamo-100mg-100s (Lamo 100mg 100s)

Lamotrigine Tablets, USP 100 mg oral tablets label from Ascend Laboratories, LLC. The label includes dosage strength (100 mg), quantity (100 tablets), storage instructions, manufacturer Alkem Laboratories Ltd. Mumbai, and distributor Ascend Laboratories, LLC, Parsippany, NJ. It contains a barcode and cautions to verify product dispensed and to dispense the accompanying Medication Guide.*

FDA Label Image

Lamo-150mg-60s (Lamo 150mg 60s)

Label for Lamotrigine tablets USP 150 mg by Ascend Laboratories, LLC. The label shows the product name and strength, dosage form as tablets, and a quantity of 60 tablets. It includes storage instructions, manufacturer details (Alkem Laboratories Ltd., Mumbai, India), and distribution information. The label features a barcode and a caution to verify the product dispensed.*

FDA Label Image

Lamo-200mg-60s (Lamo 200mg 60s)

Lamotrigine Tablets, USP 200 mg oral tablet label by Ascend Laboratories, LLC. The label states each scored tablet contains 200 mg lamotrigine and includes storage instructions, distributor information, and a 60-tablet count. The label also features warnings to dispense the medication guide and verify product dispensed, with the manufacturer listed as Alkem Laboratories Ltd.*

FDA Label Image

Lamo-25mg-100s (Lamo 25mg 100s)

Lamotrigine 25 mg tablets label by Ascend Laboratories, LLC showing the product name and strength prominently. It includes dosage form as tablets, package size of 100 tablets, storage instructions, and manufacturing details by Alkem Laboratories Ltd, India. The label also displays NDC 67877-164-01 and cautions to verify product dispensed and provide a medication guide.*

FDA Label Image

Lamo-fig-1 (Lamo Fig 1)

A Kaplan-Meier survival curve chart showing failure probability over weeks. Two curves compare Lamotrigine and Placebo groups, with failure probability on the Y-axis (0-100%) and time in weeks on the X-axis (0-100). '+' symbols indicate censored data points.*

FDA Label Image

Lamo-fig-2 (Lamo Fig 2)

A Kaplan-Meier plot showing failure probability (%) over time in weeks for Lamotrigine versus placebo. The graph compares failure probabilities, with the Lamotrigine curve consistently lower than placebo, indicating differences in outcomes between the two groups over approximately 80 weeks.*

FDA Label Image

Lamo-tab Structure (Tab Strcture)

Lamotrigine oral tablets in different strengths: 25 mg, 100 mg, 150 mg, and 200 mg. Each tablet is triangular-shaped, scored on one side, and imprinted with numbers corresponding to the strength (278 for 25 mg, 277 for 100 mg, 276 for 150 mg, and 275 for 200 mg). The labeler is Ascend Laboratories, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.